Cancer / Oncology News From Medical News TodayLatest Cancer / Oncology News From Medical News Today.Cancer Physician Invents Test For New Drugs That Cut Off Tumor's Blood Supply- August 13, 2008 Today's online edition of theJournal of Internal Medicinereports discovery of the first practical laboratory test to guide the use of new-generation drugs that kill cancer cells by cutting off their blood supply. The new test, called the Microvessel Vascular (MVV) assay, was developed by Larry Weisenthal, MD, PhD., a medical oncologist who operates a cancer testing laboratory in Huntington Beach, California.http://www.medicalnewstoday.com/articles/118108.php U.S. NCI Starts Enrolment In Phase 2 Systemic Melanoma Clinical Trial With REOLYSIN(R)- August 13, 2008 Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced that the U.S. National Cancer Institute (NCI), part of the National Institutes of Health, has started enrolment in a Phase 2 clinical trial for patients with metastatic melanoma using systemic administration of REOLYSIN(R), Oncolytics' proprietary formulation of the human reovirus.http://www.medicalnewstoday.com/articles/118058.php First Reported Video Of Cell's Recognition Of Danger Through Its Protein Response- August 13, 2008 Cells are expected to respond defensively when an antigen lands on a cell membrane and prepares to cause mischief. But to activate a response, a cell must become aware of the presence of the intruder on its membrane, just as a human first must become aware of a mosquito on a forearm in order to slap it.http://www.medicalnewstoday.com/articles/118069.php Cholesterol Drug Plays Role In Melanoma Remission- August 13, 2008 A drug widely used to treat high cholesterol is helping beat cancer. Lovastatin is part of a new cancer treatment that has arrested or eradicated tumors in more than 80% of initial patients. The first person treated with the investigative protocol in 2000 had stage 4 melanoma; he remains disease-free today. Lovastatin, the first of the statin group of lipid fighters, was introduced in 1980.http://www.medicalnewstoday.com/articles/118059.php Cancer Cells With A Long Breath: Seeking The Origin Of Brain Tumours In Children- August 13, 2008 Medulloblastoma is one of the most common and most malignant brain tumours among children and teenagers. These tumours grow very rapidly, and fifty percent of patients in the long term die from the condition. The details of the processes that lead to the growth of these tumours have remained unknown until now. In two studies, working together with international scientific teams, LMU medical scientist Dr.http://www.medicalnewstoday.com/articles/118072.php Key To Treating Cancer May Be Finding Its Original Cell- August 13, 2008 Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity. "Identifying the specific, normal cells that cancers come from can provide critical insight into how cancers develop," said Robert Wechsler-Reya, an associate professor of Pharmacology and Cancer Biology at Duke University Medical Center.http://www.medicalnewstoday.com/articles/118013.php Scientists Use Old Enemy To Knock Out Cancer- August 13, 2008 Chemists are pulling cancer onto a sucker punch by getting infected cells to drop their guard - according to research published recently. They are using the metal ruthenium as a catalyst to a cancer-busting reaction which calls up an old cellular enemy - oxidants - as an ally. Cancer adapts quickly to traditional drugs which attack infected cells directly.http://www.medicalnewstoday.com/articles/118047.php VitiGam Inhibits Melanoma Growth In A Dose Dependent Manner - Inhibition Of Tumor Growth Is Statistically Significant- August 13, 2008 GammaCan International, Inc. (OTCBB: GCAN), a developer of proprietary immunotherapies for the treatment of melanoma and other cancers, announced further progress in its VitiGam development program. In preparation for its upcoming IND submission for VitiGam, the Company successfully completed additional experiments using its established mouse melanoma model.http://www.medicalnewstoday.com/articles/118034.php Blue Cross Blue Shield Of Michigan-American Society Of Clinical Oncology Initiative To Reduce Costs, Improve Patient Care- August 12, 2008 Blue Cross Blue Shield of Michigan and the American Society of Clinical Oncology are collaborating to collect and analyze treatment information on tens of thousands of people with cancer in Michigan in an effort to improve care and reduce costs, the Detroit News reports.http://www.medicalnewstoday.com/articles/117967.php Depression Prompts Thoughts Of Death In Cancer Patients- August 12, 2008 Cancer patients are three times more likely to think they would be "better off dead" or to contemplate suicide than the rest of the population - a Cancer Research UK study reports online today. Patients were most likely to have these thoughts if they had substantial pain and particularly if they had serious emotional distress. The study highlights the need for morehttp://www.medicalnewstoday.com/articles/118002.php |